I believe when submitting trial applications to FDA etc a time...

I believe when submitting trial applications to FDA etc a time line or length of trial is to be submitted on application. This is also requested by the authorising agency. The trial time line is usually an estimate by the chief research officer so the trial may be less than the estimated time line, or as estimated, or longer. Communication recently from Prof. Yuman Fong and from CEO L C indicates favourable results though Depending on each individual’s interpretation and sentiment towards IMU one’s feelings maybe alternate to mine. I am going off memory here ( that’s why I’m in ACW, because of failing memory) that Leslie Chong mentioned in a video presentation that IMU are
looking for 60% to 90% efficacy, something similar to that. Anyway we’ll find out in the end. GLTAH.